Fiona Dunlevy
Direktor/Vorstandsmitglied bei MALIN CORPORATION PLC
Profil
Fiona Dunlevy currently works at Malin Corp.
Plc, as Secretary & Executive Director from 2023, Wavebreak Therapeutics Ltd., as Director from 2018, Chartered Accountants Ireland, as Associate, and Irish Taxation Institute, as Associate.
Aktive Positionen von Fiona Dunlevy
| Unternehmen | Position | Beginn |
|---|---|---|
| MALIN CORPORATION PLC | Direktor/Vorstandsmitglied | 27.10.2023 |
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Direktor/Vorstandsmitglied | 29.11.2018 |
Irish Taxation Institute
 Irish Taxation Institute Miscellaneous Commercial ServicesCommercial Services Irish Taxation Institute provides tax education to the businesses, multinationals and individuals. The company was founded on November 10, 1967 and is headquartered in Dublin, Ireland. | Corporate Officer/Principal | - |
| Chartered Accountants Ireland | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MALIN CORPORATION PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Irish Taxation Institute
Irish Taxation Institute Miscellaneous Commercial ServicesCommercial Services Irish Taxation Institute provides tax education to the businesses, multinationals and individuals. The company was founded on November 10, 1967 and is headquartered in Dublin, Ireland. | Commercial Services |
